Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/07/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1575 publications
Efficacy and safety of urate-lowering therapies in asymptomatic hyperuricaemia: a systematic review and network meta-analysis of key clinical outcomes.
Journal: Annals of medicine
Published: December 11, 2025
Network pharmacology combined with ultra-high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry method to explore the mechanism of Shizhi Fang in treating uric acid nephropathy mice.
Journal: Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan
Published: December 11, 2025
Febuxostat effectively and safely reduces serum urate in gout patients with chronic kidney disease: A prospective multicenter ULTRA registry study.
Journal: The Journal of rheumatology
Published: December 01, 2025
Cardiovascular morbidity and mortality in gout: is gout an Independent risk Factor?
Journal: Expert opinion on pharmacotherapy
Published: November 30, 2025
Novel Isoidide Subunit-Containing Xanthine Oxidase Inhibitors with Potent Hypouricemic Effects.
Journal: Journal of medicinal chemistry
Published: November 28, 2025
Febuxostat attenuates cyclophosphamide-induced ovarian toxicity; Role of TLR4/NFκB/NLRP3 signaling pathway in female Wistar albino rats.
Journal: Immunopharmacology and immunotoxicology
Published: November 04, 2025
Allopurinol-Associated Bullous Fixed Drug Eruption With Cross-Reaction to Febuxostat.
Journal: American journal of therapeutics
Published: October 30, 2025
Febuxostat Versus Allopurinol Use in Gout Patients: A Real-World Study.
Journal: Cureus
Published: October 25, 2025
Effectiveness and Safety of the Novel Selective Urate Reabsorption Inhibitor Dotinurad After Switching from Febuxostat in Patients with Stage B/C Heart Failure.
Journal: Drugs - real world outcomes
Published: October 15, 2025
The Effect of Febuxostat on Kidney Outcomes in Patients with Chronic Kidney Disease and Asymptomatic Hyperuricemia: A Target Trial Emulation.
Journal: American journal of nephrology
Published: September 26, 2025
Reply to "Febuxostat use is associated with a significantly greater risk of mild to moderate perturbation of liver function compared to benzbromarone in patients with gout: comment on the article by Sun et al".
Journal: Arthritis care & research
Published: September 23, 2025
Last Updated: 01/07/2026